Addressing Subgroup-Specific Treatment Effects to Avoid Inefficient Care: The Conflict Between Statistical and Health Economic Analyses
When subgroup heterogeneity is known, ignoring subgroups or taking a statistically guided approach will result in suboptimal reimbursement decisions and thus fail to optimize societal benefits. Therefore, subgroup-specific cost-effectiveness analyses should be informed by all available evidence of subgroup differences.
Authors
- Hendrik Koffijberg (ORCID: https://orcid.org/0000-0002-1753-0652)
- Gerjon Hannink (ORCID: https://orcid.org/0000-0001-9526-3775)
- Sopany Saing (ORCID: https://orcid.org/0000-0001-5913-9654)
- H Amarens Geuzinge
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- Zorginstituut Nederland (NL)
Publication Details
- Journal
- Value in Health
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1016/j.jval.2025.05.004
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00